|Bid||426.85 x 1000|
|Ask||427.20 x 800|
|Day's range||425.19 - 441.99|
|52-week range||63.64 - 497.49|
|Beta (5Y monthly)||1.48|
|PE ratio (TTM)||50.41|
|Earnings date||27 Oct 2021 - 01 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||312.08|
Anjalee Khemlani joins Julie Hyman to take an in-depth analyst on the FDA meeting to determine the efficacy of promoting COVID-19 booster shots at this moment in time and what the impact of this decision could mean for the nation going forward.
Dr. Jabraan Pasha, internal medicine physician at University of Oklahoma Medical Center in Tulsa, joins the Yahoo Finance Live panel to discuss the latest COVID-19 developments
Investors are nervous about a Food and Drug Administration advisory panel meeting and optimistic about a World Health Organization decision.